This page is part of the Quality Improvement Core Framework (v7.0.0: STU7 (v7.0.0)) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version. For a full list of available versions, see the Directory of published versions
Page standards status: Informative |
Profile: QICore Medication
code: alemtuzumab 10 MG/ML [Lemtrada]
manufacturer: Organization Genzyme
form: Conventional release solution for injection (dose form)
Item[x] | Strength |
Alemtuzumab (substance) | 12 mg (Details: UCUM codemg = 'mg')/1.2 mL (Details: UCUM codemL = 'mL') |
LotNumber | ExpirationDate |
9494788 | 2017-05-22 |
Generated Narrative: Organization #org6
Profile: QICore Organization
identifier: United States National Provider Identifier/8635143786 (use: temp, )
active: true
name: Genzyme
telecom: https://www.sanofigenzyme.com/
address: Cambridge MA USA (work)